The Lipid Metabolism Gene FTO Influences Breast Cancer Cell Energy Metabolism Via the PI3K/AKT Signaling Pathway

Overview

Journal Oncol Lett

Specialty Oncology

Date 2017 Jun 11

PMID 28599470

Citations 44

Authors

Yazhuo Liu

Ruoyu Wang

Lichuan Zhang

Jianhua Li

Keli Lou

Bingyin Shi

Affiliations

Soon will be listed here.

Abstract

The present study assessed the effect of the lipid metabolism, fat mass and the obesity-associated gene (FTO), on energy metabolism of breast cancer cells. The human breast cancer cell lines, MCF-7 and MDA-MB-231, and HCC1937 human breast cells were studied. Real-time PCR was used to measure the levels of FTO mRNA from breast cancer cells and normal breast cells. MDA-MB-231 cells were transfected with miFTO inhibitor or inhibitor control, and cells were assessed for levels of lactic acid, ATP, pyruvate kinase activity, and hexokinase activity assay using specific kits. Western blot analysis was used to measure the levels of phosphatidylinositol 3-kinase (PI3K), p-PI3K, protein kinase B (Akt) and p-Akt in transfected breast cancer cells. The expression of FTO was significantly increased in MCF-7 and MDA-MB-231 cells compared with HCC1937 cells (P<0.01). The lactic acid content of breast cancer cells transfected with the miFTO inhibitor was significantly lower compared with cells transfected with the miFTO inhibitor control and nontransfected cells (P<0.05). The ATP content of breast cancer cells transfected with the miFTO inhibitor was significantly lower compared with the control group and inhibitor control group (P<0.05). The pyruvate kinase activity and hexokinase activity of breast cancer cells transfected with the miFTO inhibitor were significantly lower compared with the control group and inhibitor control group (P<0.01). Western blot analysis showed that after breast cancer cells were transfected with the miFTO inhibitor, the levels of PI3K, p-PI3K, Akt and p-Akt were significantly lower than in the control group and inhibitor control group. In conclusion, the FTO gene is overexpressed in breast cancer cells. Overexpression of the FTO gene can promote breast cancer cell glycolysis and the mechanism is related to the PI3K/AKT signaling pathway.

Citing Articles

Identification of key LncRNAs and mRNAs associated with intramuscular fat in pig via WGCNA.

Li W, Yang S, Liu H, Cao Z, Xu F, Ning C BMC Genomics. 2025; 26(1):233.

PMID: 40069611 PMC: 11895181. DOI: 10.1186/s12864-025-11427-x.

Glycolysis modulation: New therapeutic strategies to improve pulmonary hypertension (Review).

Chen M, Li H, Li Y, Luo Y, He Y, Shui X Int J Mol Med. 2024; 54(6).

PMID: 39422043 PMC: 11518579. DOI: 10.3892/ijmm.2024.5439.

Insights into the mA demethylases FTO and ALKBH5 : structural, biological function, and inhibitor development.

Gao Z, Zha X, Li M, Xia X, Wang S Cell Biosci. 2024; 14(1):108.

PMID: 39192357 PMC: 11351023. DOI: 10.1186/s13578-024-01286-6.

Functions and mechanisms of RNA mA regulators in breast cancer (Review).

Yang Y, Gao F, Ren L, Ren N, Pan J, Xu Q Int J Oncol. 2024; 65(3).

PMID: 39054967 PMC: 11299767. DOI: 10.3892/ijo.2024.5674.

Treatment of Donor Cells with Oxidative Phosphorylation Inhibitor CPI Enhances Porcine Cloned Embryo Development.

Cao J, Dong Y, Li Z, Wang S, Wu Z, Zheng E Animals (Basel). 2024; 14(9).

PMID: 38731366 PMC: 11083069. DOI: 10.3390/ani14091362.

References

Piccart-Gebhart M, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I . Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med. 2005; 353(16):1659-72. DOI: 10.1056/NEJMoa052306. View

Gatenby R, Gillies R . Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004; 4(11):891-9. DOI: 10.1038/nrc1478. View

Sevgi M, Rigoux L, Kuhn A, Mauer J, Schilbach L, Hess M . An Obesity-Predisposing Variant of the FTO Gene Regulates D2R-Dependent Reward Learning. J Neurosci. 2015; 35(36):12584-92. PMC: 6605390. DOI: 10.1523/JNEUROSCI.1589-15.2015. View

Milagro F, Moreno-Aliaga M, Martinez J . FTO Obesity Variant and Adipocyte Browning in Humans. N Engl J Med. 2016; 374(2):190-1. DOI: 10.1056/NEJMc1513316. View

Liang M, Liu J, Ji H, Chen M, Zhao Y, Li S . A Aconitum coreanum polysaccharide fraction induces apoptosis of hepatocellular carcinoma (HCC) cells via pituitary tumor transforming gene 1 (PTTG1)-mediated suppression of the P13K/Akt and activation of p38 MAPK signaling pathway and displays.... Tumour Biol. 2015; 36(9):7085-91. DOI: 10.1007/s13277-015-3420-4. View

Yang Z, Xie C, Xu W, Liu G, Cao X, Li W . Phosphorylation and inactivation of PTEN at residues Ser380/Thr382/383 induced by Helicobacter pylori promotes gastric epithelial cell survival through PI3K/Akt pathway. Oncotarget. 2015; 6(31):31916-26. PMC: 4741650. DOI: 10.18632/oncotarget.5577. View

Zhu J, Cui Y, Cui K, Li X, Zhang Z . Distinct roles of parafibromin in the extracellular environment, cytoplasm and nucleus of osteosarcoma cells. Am J Transl Res. 2016; 8(5):2426-31. PMC: 4891456. View

Barbier-Torres L, C Delgado T, Garcia-Rodriguez J, Zubiete-Franco I, Fernandez-Ramos D, Buque X . Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. Oncotarget. 2015; 6(4):2509-23. PMC: 4385867. DOI: 10.18632/oncotarget.3191. View

Mock C, Jordan B, Selvam C . Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment. RSC Adv. 2016; 5(92):75575-75588. PMC: 4836288. DOI: 10.1039/C5RA14925H. View

10.

Bains M, Roberts J . Estrogen protects against dopamine neuron toxicity in primary mesencephalic cultures through an indirect P13K/Akt mediated astrocyte pathway. Neurosci Lett. 2015; 610:79-85. PMC: 4695379. DOI: 10.1016/j.neulet.2015.10.054. View

11.

Pande M, Bondy M, Do K, Sahin A, Ying J, Mills G . Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival. Breast Cancer Res Treat. 2014; 147(2):381-7. PMC: 4174407. DOI: 10.1007/s10549-014-3081-9. View

12.

Zhang C, Wang X, Wang H, Cai Y, Chao L . Sorafenib inhibits liver cancer growth by decreasing mTOR, AKT, and PI3K expression. J BUON. 2015; 20(1):218-22. View

13.

Hasstedt S, Coon H, Xin Y, Adams T, Hunt S . APOH interacts with FTO to predispose to healthy thinness. Hum Genet. 2015; 135(2):201-7. PMC: 4715708. DOI: 10.1007/s00439-015-1629-3. View

14.

Valenti D, Vacca R, de Bari L . 3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system. J Bioenerg Biomembr. 2015; 47(6):493-506. DOI: 10.1007/s10863-015-9631-y. View

15.

Vincent E, Sergushichev A, Griss T, Gingras M, Samborska B, NTimbane T . Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth. Mol Cell. 2015; 60(2):195-207. DOI: 10.1016/j.molcel.2015.08.013. View

16.

Roberts D, Miyamoto S . Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy. Cell Death Differ. 2014; 22(2):248-57. PMC: 4291497. DOI: 10.1038/cdd.2014.173. View

17.

Gallagher E, LeRoith D . Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Physiol Rev. 2015; 95(3):727-48. PMC: 4491542. DOI: 10.1152/physrev.00030.2014. View

18.

Gimenez-Cassina A, Danial N . Regulation of mitochondrial nutrient and energy metabolism by BCL-2 family proteins. Trends Endocrinol Metab. 2015; 26(4):165-75. PMC: 4380665. DOI: 10.1016/j.tem.2015.02.004. View

19.

Kuchenbaecker K, Ramus S, Tyrer J, Lee A, Shen H, Beesley J . Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nat Genet. 2015; 47(2):164-71. PMC: 4445140. DOI: 10.1038/ng.3185. View

20.

. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015; 386(10001):1341-1352. DOI: 10.1016/S0140-6736(15)61074-1. View